Source Personalized Medicine Experts for your Project, Phone Consult or Job

Submit an anonymous Inquiry -- Start receiving responses within a few hours

Have a need? Explain it here

Zintro does not display, sell or trade e-mail addresses

An eye iconForgot password?
Submit Inquiry

By clicking Submit Inquiry you agree to our TermsVIEW

or Request Pricing Information

How Zintro Works

  1. 1. Provide a clear description of your needs and your expectations of an expert, consultant or job candidate and Zintro will match it with the most relevant professionals in our platform.
  2. 2. Within a day or two typically 6 - 12 Experts, who have opted-in, will contact you with a brief explanation of their qualifications and how they can help.
  3. 3. You can communicate back and forth, qualify each other, connect and pay fees to Experts through Zintro.
  4. Zintro is free, anonymous and without obligation.

Loved by Thousands

Loved by thousands logos

Need Help?A phone icon1-877-236-7016

Recent Personalized Medicine Inquiries

Area Icon

Personalized Medicine

Hello, we are interested in understanding better how sales force for leading pharma is changing in the face of personalised medicine revolution. Are reps co-promoting diagnostic testing? Who is training them in pm? How are they targeting docs? Interested in any large/mid size pharma with pm therapies with clear diagnostic strategy on market or in the pipeline. Thanks and have a good day.

  1. Profile Picture

    Michael |CMSO , Chief Medical Strategies Officer

    Hi We presently have contracts that are both global and domestic (USA). We are also working with var...

    6.8 Hours Later
  2. Profile Picture

    Kuldeepak |Director

    Thanks for your message. As a pharmaceutical medical device consultant & Ph.D. in pharmaceutics medi...

    7.5 Hours Later
  3. Profile Picture

    Terry |President

    I have first hand experience with developing companion diagnostics for large Pharma in my previous p...

    9.3 Hours Later
+6 Other Responses
Area Icon

Pharmaceutical Secondary Market Research

I am currently looking for an expert from pharmaceutical/healthcare industry (preferably ex-employees of major pharma companies) who knows in and out about secondary market research category (ims health data) in terms of developing strategy, types of data, strengths, weakness, threats and case examples for data purchase? Thank you, seenivas

  1. Profile Picture

    Polina |Oversight & Monitoring Lead, Health Care

    Hi Seenivas, I oversee MR activities and partnerships with IMS among several other vendors from whom...

    9.3 Hours Later
  2. Profile Picture

    Alex |VP, Business Development & Commercial Op

    I have 12+ years in the industry. I spent 6 years with ZS Associates, a leading consulting firm spec...

    9.8 Hours Later
  3. Profile Picture

    C.P. |Independent Pharmaceuticals Professional

    Dear Seenivas Ji, I am Shastry, from Pharma Synergies, India. I am an 'Independent *****ma...

    21.6 Days Later
+8 Other Responses
Area Icon

Pharmaceutical Contract Sales

Project : study on pharmaceutical companies sourcing sales reps from contract sales organizations industry: pharmaceuticals, contract sales scope: australia, belgium, netherlands, saudi arabia, puerto rico, venezuela. We are doing a project on procuring sales force from contract sales organizations in various markets. Request expert guidance in understanding the procurement best practices followed by leading pharmaceutical companies while sourcing contract sales reps from contract sales organizations

  1. Profile Picture

    Shyam |CFO Advisor

    Just completed a major contract sales *****y for a large global procurement consulting f...

    41 Minutes Later
  2. Profile Picture

    Rita |Principle

    Dear B-COM-Z-MAS, I can certainly assist you with this for the following countries, Australia, Belgi...

    3.7 Hours Later
  3. Profile Picture

    Shrinivas |CEO

    I can handle this project since we are into it for major MNCs . Rgds Shrinivas.Muthangi...

    17.9 Hours Later
+9 Other Responses
Area Icon

Pharmaceutical Distribution Rates

I am currently working for a pharmaceutical/healthcare client based in the us. My client is looking for benchmark discounted rates offered for distribution of their products in the us. Below are the deliverable details for which i am looking for benchmarked/industry average discounted rates in the us 1) volume ranges per day i) 10,000-50,000 ii) 50,000- 100,000 iii) >100,000 2) discounted rates offered for the above-mentioned volume ranges based on the type of supplier mentioned below i) global supplier (international suppliers operating across the globe) - how much % of discount is offered for the above-mentioned volume ranges ii) local supplier (suppliers operating within the country) - how much % of discount is offered for the above-mentioned volume ranges iii) regional supplier (suppliers operating in more than 1 country) - how much % of discount is offered for the above-mentioned volume ranges kindly revert back if the above is feasible regards anjana

    +undefined Other Responses
    Area Icon

    Healthcare Promotional Items

    Title: promotional items one of our leading pharmaceutical clients is interested to learn about the promotional items offered to the healthcare professionals and pharmacists. Expert insights are needed on the industry overview, procurement best practices and slas, pricing models and cost structure in the following countries: australia, austria, belgium, denmark, finland, france, germany, greece, ireland, italy, netherlands, new zealand, norway, poland, portugal, spain, sweden, switzerland, turkey, united kingdom

    1. Profile Picture

      Jim |Managing Partner

      I have extensive experience in pharmaceutical promotional practices having served in both sales and ...

      44 Minutes Later
    2. Profile Picture

      Hanno |Owner

      Lerb me know what you need, I could give an overview of many countries especially around compliance ...

      2.9 Hours Later
    3. Profile Picture

      Martin |President & CEO

      I know someone else dealing in medical, healthcare and pharma promotional items. He has many interes...

      8.4 Hours Later
    +15 Other Responses
    Area Icon

    Pharmaceuticals, Vaccines And Consumer Products Distribution

    "pharmaceuticals, vaccines and consumer products-distribution sourcing" geography: europe 1. Sourcing best practice a. What are the sourcing approaches followed by global organizations when dealing with distributors/wholesalers across pharmaceutical, consumer and vaccine business? (centralized/decentralized) 2. Engagement best practice a. What is the best practice followed by companies when engaging for distribution services across pharmaceutical, consumer and vaccine business? I. Is it engaging with a distributor or wholesaler? · global/regional/local distributors? · single or multiple distributors? 3. Feasibility of integrating the distribution model for pharmaceuticals, consumer and vaccine business a. How do companies with multiple business units such as pharmaceutical, consumer and vaccine business manage this category? I. Is there a chance of integrating the distribution of these three business units with single set of distributors? Ii. What are the advantages and disadvantages of following the integration approach?

    1. Profile Picture

      Debasish |HEAD SUPPLY CHAIN

      Please refer my profile...

      6.6 Hours Later
    2. Profile Picture

      Eugene |Scientific Director

      Hello. I can help. I'm GDP Expert, Director of CRO and ex Marketing Director in Big Pharma....

      6.7 Hours Later
    3. Profile Picture

      Polina |Oversight & Monitoring Lead, Health Care

      I can speak from a procurement perspective. Would you like to schedule a call for next week?...

      7.7 Hours Later
    +9 Other Responses
    Area Icon

    Creative Services For Pharmaceuticals

    Creative and digital agency for pharmaceuticals sourcing strategy - what is the best sourcing model for creative and digital services for pharmaceutical companies? - what is the sourcing approach followed typically by leading pharmaceutical companies? (full-service model or specialized agency model)? - do large pharma/vaccines companies bundle digital and creative work to single agencies? Pricing models - what is the most optimal pricing model while engaging with digital and creative agencies to assure transparency and control of costs? - is fixed price or performance based pricing or any other? - i would like to understand if fixed price model is most effective pricing model to control costs while engaging with creative and digital agencies.

    1. Profile Picture

      Bob |Creative Director/Strategist

      I have consulted brands on the budget and ***** marketing and advertising *****...

      40 Minutes Later
    2. Profile Picture

      Camille |CEO of Online Business Services Provider

      To answer some of your questions I would need to be more familiar with your particular constraints; ...

      1.8 Hours Later
    3. Profile Picture

      C. Yume |Digital Project Manager, Digital Produce

      I'll give you a tip from working for Digital Agencies many years before becoming a digital consultan...

      1.9 Hours Later
    +10 Other Responses
    Area Icon

    Consumer Health

    Vaccines, consumer healthcare and pharma : market size, growth rate and growth forecast for 1) consumer healthcare categories : . Oral healthcare â· nutrition â· pain â· wellness 2)pharmaceutical market 3)vaccines market regions in focus: south east asia singapore malaysia indonesia thailand vietnam philippines greater china prc taiwan hong kong japan south korea australia new zealand

    1. Profile Picture

      Divya |Director Editorial Company Nam

      Hi, I am interested in your project. I would like to know more about it. Let me know further details...

      25 Minutes Later
    2. Profile Picture

      Mohammad Sami |Manager Business Development

      Dear Sir Your inquiry is ***** my expertise, as i was involve with the market development in...

      1.6 Hours Later
    3. Profile Picture

      David |CEO

      Hello, I am David Gyori and I am writing to you on behalf of my small company, Xallis Consulting, re...

      5 Hours Later
    +7 Other Responses
    Area Icon

    Pharmaceuticals Reverse Logistics

    We are looking to do multiple paid phone consultations with experts from pharmaceutical returns providers with recent experience not more than 2 years ago. We would like to get a better understanding of learning about the operational capability and capacity of different niche market players to handle returns of controlled substances prescriptions on behalf of retailers and manufacturers. This is a 1-hour paid phone consult. Please consider summarizing your relevant experience with short answers to the questions below: 1. Can you discuss how pharma companies generate data for overstocked, expired and in-dated pharmaceutical products? 2. Can you share the major challenges in handling returns of controlled substances prescriptions on behalf of retailers and manufacturers? 3. Can share your insight on the operational capability and capacity of different niche market players?

      +undefined Other Responses
      Area Icon

      International Pharmaceutical Reimbursement

      Hello, on one for our projects on neuropathic pain and schizophrenia/major depressive disorder we are looking for reimbursement experts and regulator experts who have knowledge and worked in/on emerging markets (china, india, taiwan, korea, mexico, turkey, russia, brazil, australia, canada). We need one expert for each of the countries; china, india, taiwan, korea, mexico, turkey, russia, brazil, australia, canada. A few requirements of such experts are listed below, according relevant experts may please forward their responses asap. Regulatory expert: § knowledgeable about drug approval process/guidelines (particularly for indications of interest)in the country § knowledgeable about regulations for conducting clinical trials in the country § knowledgeable about similarities & differences in regulations/guidelines their specified country vs. Us/eu (especially related to branded vs. Generic medications) reimbursement expert: § knowledgeable about national reimbursement policies/procedure followed in the country (particularly for drugs used in indications of interest) § knowledgeable about pharmaceutical pricing policies in the country § knowledgeable about access to healthcare in the country § knowledgeable about reimbursement procedure/ formulary inclusion process (particularly for indications of interest)for drugs in the country note: regulatory expert/reimbursement expert can be from public organizations or private organizations or independent consultants and may not be located in any part of the world. Interested members can reply to this post asap and communicate with me. Thanks and regards

      1. Profile Picture

        Richard |Principle... Independent Contract Consul

        Hello: Thank you for the invite to this project. I cannot speak to reimbursement issues mentioned....

        1 Hour Later
      2. Profile Picture

        Andrew |Owner & Chief Consultant

        I can cover the China *****ronments. I'd like to schedule a time to talk to you about your...

        1 Hour Later
      3. Profile Picture

        Michael |Consultant

        I have extensive experience with the reimbursement of new medicines in Australia....

        4.9 Hours Later
      +24 Other Responses
      Area Icon

      Pharmaceutical Market Access

      Director, market access opportunity onsite in california, usa. Overview: the director market access will be a strategic business leader responsible for developing a comprehensive reimbursement, pricing, contracting, and distribution strategy for heplisav-b in the us to support launch in 2016. In addition, the director market access will provide guidance and insights to support commercial planning for pipeline products. Responsibilities: build out the infrastructure for the pricing, contracting, distribution and payer team. Develop and execute market access strategies focused on reimbursement, pricing, contracting, and commercial distribution related to heplisav-b and future pipeline products across multiple disease states. Apply deep understanding of national and local reimbursement trends and policies, payer coding and billing, and newly forming health care delivery models to develop managed market strategies. Lead development and execution of contracting strategy for heplisav-b and future pipeline products. Lead all aspects of payer coverage to support appropriate reimbursement of heplisav-b. Develop dossier and other materials as needed to support payer acceptance. Responsible for all distributor and gpo accounts, including contract negotiations, ongoing relationship management, and day to day operational activities. Execute retail pharmacy channel distribution strategy in conjunction with product marketing. Manage 3pl activities related to interactions with distribution network. Work with commercial analytics to develop metrics/dashboards to assess performance of pricing and contracting strategy. Qualifications: at least 10 years of experience in the biotech or pharmaceutical industry; at least 5 years’ experience in a market access/reimbursement/key account position with proven success ba/bs with relevant experience; understanding of billing and coding with experience in the implementation of pricing and contracting strategy; comprehensive knowledge of us healthcare reimbursement system in both commercial and government payer; demonstrated experience with specialty pharmacy and wholesalers.

      1. Profile Picture

        Rajni |Regional Head

        Dear Manager 24 Sep 2015 I have vast experience in Infectious Diseases for ove...

        7.1 Hours Later
      2. Profile Picture

        R. |Biotech Research Analyst/Scientist

        I can do this **********te in northern CA as required....

        11.4 Hours Later
      3. Profile Picture

        Glenda |Principal Consultant

        As a pharmacist working on payer side for many years, I understand the issues surrounding market acc...

        17.8 Hours Later
      +6 Other Responses
      Area Icon

      Global Pharmaceuticals

      Hi zintro expert, the zintro blog needs you! *a brief answer to the prompt about 1-2 paragraphs including your full name *participation is voluntary no payment will be involved *if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you topic and prompt global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh challenge as the first generation of blockbuster biological drugs begins to face competition. Bristol-myers squibb and eli lilly have the strongest late-stage pipelines relative to existing revenues, while astrazeneca has shown the greatest improvement over the past two years, says a report by credit rating agency moody’s. However, those same three companies also face the greatest exposure to patent expiries over the next three years, highlighting the perennial battle faced by drugmakers to develop new medicines as old ones lose market exclusivity. What are your thoughts? Getting your name and expert opinion published on our blog is a great marketing opportunity. If interested, please send a response to the prompt via znotes within 1-2 days. Don't forget to include your full name. If you have any questions, please let us know. Thank you! the zintro blog team wondering what the post would look like? Here is a sample: http://blog.Zintro.Com/2014/08/14/rosetta-completes-10-year-trip-deep-space />

      1. Profile Picture

        Dr. Sumant |Biopharma Biologics Process and Manufact

        New biological molecules development is very important to sustain the pharma market in future decade...

        4.1 Hours Later
      2. Profile Picture

        Sanjeev |Consultant

        I think that near *****ry of drugs need to be aligned with pricing adjustments so as these com...

        4.8 Hours Later
      3. Profile Picture

        Umberto |Previously: COO, VP & Director Regulator

        This is the plight of big pharma. How do you keep the pipeline fresh: ***** discover new...

        17.2 Hours Later
      +4 Other Responses
      See More Inquiries

      Personalized medicine is the concept that information about a patient's genotype or gene expression profile could be used to tailor medical care to an individual's needs. Such information could be used to help stratify disease status, select between different medications and/or tailor their dosage, provide a specific therapy for an individual's disease, or initiate a preventative measure that is particularly suited to that patient at the time of administration. Several examples of approaches to personalized medicine have been established in medical practice, but in general the genotype-centered approach is not yet in widespread use clinically. It is currently debated whether such "personalized medicine" offers significant advantages over traditional clinical approaches that combine an individual's personal medical history, family history, and data from imaging, laboratory, and other tests.

      Top Personalized Medicine Experts

      See More Experts
      Share
      LinkedInTwitterFacebookGoogle+